Willeke de Haan

发表

Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in APOE*3-Leiden Mice

J. Jukema, L. Havekes, G. Dallinga-Thie, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin

J. Jukema, J. Romijn, L. Havekes, 2008, Circulation.

Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice

J. Jukema, L. Havekes, P. Rensen, 2008, Arteriosclerosis, thrombosis, and vascular biology.

PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice.

J. Jukema, J. Romijn, L. Havekes, 2009, Biochimica et biophysica acta.

Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.

E. Bunnik, J. Drijfhout, F. Koning, 2003, Gastroenterology.

Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression Published, JLR Papers in Press, May 24, 2007.

J. Jukema, J. Romijn, L. Havekes, 2007, Journal of Lipid Research.

Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.

J. Romijn, L. Havekes, J. A. Smit, 2009, Endocrinology.

Restoration of High-Density Lipoprotein Levels by Cholesteryl Ester Transfer Protein Expression in Scavenger Receptor Class B Type I (SR-BI) Knockout Mice Does Not Normalize Pathologies Associated With SR-BI Deficiency

D. Praticò, T. V. van Berkel, J. K. Kruijt, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Loss of Both ABCA1 and ABCG1 Results in Increased Disturbances in Islet Sterol Homeostasis, Inflammation, and Impaired β-Cell Function

James D. Johnson, M. Hayden, C. Wellington, 2012, Diabetes.

Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.

T. V. van Berkel, L. Havekes, P. Rensen, 2007, Atherosclerosis.

Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL Published, JLR Papers in Press, March 14, 2006.

L. Havekes, P. Rensen, M. Westerterp, 2006, Journal of Lipid Research.

Important Role for Bone Marrow–Derived Cholesteryl Ester Transfer Protein in Lipoprotein Cholesterol Redistribution and Atherosclerotic Lesion Development in LDL Receptor Knockout Mice

M. Jauhiainen, C. Ehnholm, T. V. van Berkel, 2007, Circulation research.

Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo.

J. Jukema, J. Romijn, K. V. van Dijk, 2008, Biochemical and biophysical research communications.

Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1

M. Hayden, A. Groen, C. Verchere, 2014, Diabetes.

Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

H. Lamb, J. Romijn, A. de Roos, 2010, Diabetes Care.

Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis

W. V. van IJcken, A. Luttun, G. Berx, 2021, Cardiovascular research.

The Hyplip2 locus causes hypertriglyceridemia by decreased clearance of triglyceridess⃞ Published, JLR Papers in Press, July 3, 2007.

A. Lusis, P. Gargalovic, R. Frants, 2007, Journal of Lipid Research.

Regulation of ABCA1 Protein Expression and Function in Hepatic and Pancreatic Islet Cells by miR-145

M. Hayden, S. Butland, Willeke de Haan, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Hepatic ABCA1 Expression Improves β-Cell Function and Glucose Tolerance

M. Hayden, J. Karasinska, Willeke de Haan, 2014, Diabetes.

Unraveling the transcriptional determinants of Liver Sinusoidal Endothelial Cell specialization.

A. Luttun, B. Smedsrød, C. Verfaillie, 2020, American journal of physiology. Gastrointestinal and liver physiology.

ABCA1 in adipocytes regulates adipose tissue lipid content, glucose tolerance, and insulin sensitivity[S]

M. Hayden, Willeke de Haan, Michael R Hayden, 2014, Journal of Lipid Research.

Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.

J. Jukema, J. Romijn, L. Havekes, 2008, Atherosclerosis.

Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice[S]

M. Manns, P. Hogendoorn, T. V. van Berkel, 2013, Journal of Lipid Research.